Eli Lilly partners with AI-focused Genetic Leap to develop RNA-based drugs
Go back to Eli Lilly partners with AI-focused Genetic Leap to develop RNA-based drugs| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1211.55 -3.47 (0.29%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1215.02 | 52 Week High | $88.16 | |||
| Open | $1201.73 | 52 Week Low | $67.88 | |||
| Day High | $1212.18 | P/E | 280.45 | |||
| Day Low | $1191.08 | EPS | $4.32 | |||
| Volume | 371,267 | |||||

